Ftse Mib
34.344,20
0,08%
DAX
20.267,98
0,07%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
104.190,80
-1,85%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Scynexis Inc (SCYX) Scynexis Inc (SCYX) Notizie

SCYX

Scynexis (SCYX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCYX
DataOraFonteTitoloSimboloCompagnia
15/11/202401:07Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SCYXScynexis Inc
06/11/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCYXScynexis Inc
06/11/202422:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCYXScynexis Inc
06/11/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCYXScynexis Inc
16/09/202414:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCYXScynexis Inc
20/06/202414:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SCYXScynexis Inc
14/02/202403:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCYXScynexis Inc
28/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCYXScynexis Inc
13/11/202323:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SCYXScynexis Inc
28/09/202302:31GlobeNewswire Inc.SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substanceNASDAQ:SCYXScynexis Inc
23/06/202322:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCYXScynexis Inc
23/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCYXScynexis Inc
09/06/202322:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCYXScynexis Inc
01/05/202322:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SCYXScynexis Inc
01/05/202322:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCYXScynexis Inc
01/05/202322:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SCYXScynexis Inc
03/04/202314:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCYXScynexis Inc
31/03/202313:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SCYXScynexis Inc
31/03/202313:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCYXScynexis Inc
30/03/202316:43Dow Jones NewsScynexis Shares Jump 60% After Licensing Deal With GSKNASDAQ:SCYXScynexis Inc
02/12/202219:15TipRanksMaxim Group Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
02/12/202212:45TipRanksSCYNEXIS (SCYX) Receives a Buy from Ladenburg Thalmann & Co.NASDAQ:SCYXScynexis Inc
10/11/202218:20TipRanksAnalysts’ Top Healthcare Picks: Larimar Therapeutics (LRMR), SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
10/11/202212:45TipRanksLadenburg Thalmann & Co. Reaffirms Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
26/10/202222:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SCYXScynexis Inc
26/10/202221:41TipRanksAnalysts Offer Insights on Healthcare Companies: Immunic (IMUX), SCYNEXIS (SCYX) and Karuna Therapeutics (KRTX)NASDAQ:SCYXScynexis Inc
16/08/202219:40TipRanksAnalysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Clene (CLNN)NASDAQ:SCYXScynexis Inc
16/08/202212:05TipRanksH.C. Wainwright Remains a Buy on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
16/08/202203:05TipRanksBrookline Capital Markets Keeps Their Buy Rating on SCYNEXIS (SCYX)NASDAQ:SCYXScynexis Inc
15/08/202222:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCYXScynexis Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCYX

La tua Cronologia

LSE
9IJ1
Morti. Btl 52
ASX
IJH
BlackRock Investment Man...
BMF
FRCN25
FRCN25 - 07/2025
BMF
SWIJ25
SWIJ25 - Abril 2025
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network